- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02031653
Comparison Between Invasive Pressure Flow Study and Non-invasive Penile Cuff Test
November 28, 2019 updated by: KYU-SUNG LEE, Samsung Medical Center
To provide evidence of promising tests to noninvasively diagnose bladder outlet obstruction (BOO) in men with benign prostatic hyperplasia.
- Penile cuff test provides a means of obtaining a urodynamic diagnosis with a high level of accuracy without the morbidity and expense of invasive Pressure flow study.
- Penile cuff test may be particularly useful in the counseling of patients prior to benign prostatic hyperplasia operation. Patients diagnosed as obstructed following a penile cuff test can be reassured that surgery has a high chance of resulting in symptomatic benefit
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
335
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul,, Korea, Republic of, 130-710
- Samsung Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Sampling Method
Non-Probability Sample
Study Population
Male patients with Low Urinary Tract Symptoms over 6 months.
Description
Inclusion Criteria:
- Male patients with Low Urinary Tract Symptoms over 6 months. (International prostatic symptom score >= 12)
- Patients scheduled to have pressure flow study.
- Able to give fully informed consent
Exclusion Criteria:
- Patients with urologic malignancies such as prostate cancer and bladder cancer
- Patients underwent urethral, prostate surgery
- Patients with urethral stricture or bladder diverticulum or bladder neck contracture
- seems not to be appropriate to this study by the decision of investigators because of any other reasons
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Study Group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The Positive/Negative Predictive Value of Penile cuff test
Time Frame: 5 hours
|
5 hours
|
|
The proportion comparison of Good responder between obstructed and unobstructed patients in penile cuff test
Time Frame: up to 3 months
|
good responder: The reduction in the International Prostatic Symptom Scores of more than 50% from the initial scores 3 months after operation.
|
up to 3 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The correlation of intra-vesical Pressure between Pressure flow study and penile cuff test
Time Frame: 5 hours
|
5 hours
|
The difference of Pain visual analogue scale score between two diagnostic tests
Time Frame: 5 hours
|
5 hours
|
The categorical change of penile cuff test normogram after BPH operation
Time Frame: up to 3 months
|
up to 3 months
|
The PSA level change after benign prostatic hyperplasia operation in obstructed and non-obstructed patients.
Time Frame: up to 3 months .
|
up to 3 months .
|
The changes of International Prostatic Symptom Scores after BPH operation.
Time Frame: up to 3 months
|
up to 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2014
Primary Completion (Actual)
July 1, 2017
Study Completion (Actual)
December 1, 2017
Study Registration Dates
First Submitted
January 8, 2014
First Submitted That Met QC Criteria
January 8, 2014
First Posted (Estimate)
January 9, 2014
Study Record Updates
Last Update Posted (Actual)
December 2, 2019
Last Update Submitted That Met QC Criteria
November 28, 2019
Last Verified
November 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2013-07-151
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bladder Outlet Obstruction
-
The Cleveland ClinicCompletedProphylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate AdenocarcinomaProstate Cancer | Post-Brachytherapy Bladder Outlet ObstructionUnited States
-
Weill Medical College of Cornell UniversityPfizerCompletedBladder Outlet ObstructionUnited States
-
Meir Medical CenterUnknownBladder Outlet ObstructionIsrael
-
P. Square Medical LtdSuspendedBladder Outlet ObstructionIsrael
-
Asan Medical CenterCompleted
-
Buddhist Tzu Chi General HospitalCompletedBladder Outlet ObstructionTaiwan
-
National Taiwan University HospitalCompletedBladder Outlet Obstruction and Detrusor Underactivity in Women With Severe Cystocele
-
Astellas Pharma IncCompletedLower Urinary Tract Symptoms | Bladder Outlet ObstructionUnited States, Czech Republic, Poland, Hungary, Belgium, Germany
-
Astellas Pharma IncCompletedLower Urinary Tract Symptoms | Bladder Outlet ObstructionUnited States, Canada
-
Wellspect HealthCareCompletedLower Urinary Tract Symptoms | Bladder Outlet ObstructionUnited States, Netherlands, Poland, United Kingdom